Anticancer gene therapy regimen confers survival benefit in recurrent glioblastoma

Press/Media: Press / Media

PeriodMar 18 2020

Media coverage

1

Media coverage

  • TitleAnticancer gene therapy regimen confers survival benefit in recurrent glioblastoma
    Media name/outletHealio
    CountryUnited States
    Date3/18/20
    PersonsAndrew Brenner